Evolent Health Inc Class A (EVH)
NYSE: EVHConsumer DiscretionaryOther Consumer ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EVH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $441.11M
- Forward P/E
- 9.22
- EPS (TTM)
- -$4.46
- Dividend yield
- None
- 52-week range
- 2.10 – 6.26
- Day range
- 3.45 – 4.16
- Volume / Avg
- 4.42M / 2.16M
- Beta
- —
- Shares outstanding
- 113.11M
52-week range
EVH stock today
Shares of Evolent Health (EVH) finished higher on Nov 20 at $3.90, a gain of 13.70% or $0.47 per share, versus the S&P 500's 3.70% decline. Volume was 2.0x the average at 4.42M shares, a sign of unusually heavy trading. Shares are 37.6% below their 52-week high of $6.26, set on Jul 14, 2026 and 86.2% above the 52-week low of $2.10, in the middle of the past year's range.
EVH is down 2.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 5.8%. Evolent Health has posted a net loss over the last twelve months (EPS of -$4.46), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Evolent Health
Company profileEvolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
- Sector
- Consumer Discretionary
- Industry
- Other Consumer Services
- CEO
- Mr. Seth Barrie Blackley
- Headquarters
- Arlington, VA
- Employees
- 4,200
- IPO year
- 2015
- Website
- evolent.com
Financial highlights
Full financialsIn fiscal 2025, Evolent Health generated $1.88 billion in revenue, down 26.6% from fiscal 2024, its first annual decline since 2021. Evolent Health reported a net loss of $534.5 million, compared with a loss of $61.6 million a year earlier. Gross margin was 21.3% (up from 14.4%) and operating margin -21.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.88B | $2.55B | $1.96B | $1.35B | $907.96M |
| Growth | -26.56% | +30.09% | +45.26% | +48.91% | -1.80% |
| Net income | $-534.51M | $-61.62M | $-113.04M | $-19.16M | $-37.60M |
| EPS (diluted) | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.44 |
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$6.00+53.85%
- Strong buy 4
- Buy 8
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.21 vs $-0.05
- Surprise
- -320.00%
EVH news
All EVH news- Healthcare Stocks In Focus - ITOC +17%, EVAX +13%, IMDX +10%; AKAN And EVH See Trading ActivityNasdaqAKAN, EVAX, EVH, IMDX
- Friday's ETF Movers: IHF, AISNasdaqEVH, HUM, COHR, WDC
- Evolent Health, Inc. Reports Third Quarter 2026 Financial ResultsNasdaq
- Evolent Announces Third Quarter 2026 ResultsPR Newswire
- Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026PR Newswire
- Philips Q2 Earnings and Revenues Increase Year over Year, Shares DownNasdaqPHG, A, DXCM, EVH
Evolent Health peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BLWBlackrock Limited Duration Income Trust | 11.07 | -1.16% | $432.83M | vs EVH |
| CSVCarriage Services Inc. | 29.03 | -1.59% | $461.06M | vs EVH |
| GOTUGaotu Techedu Inc. ADR | 2.06 | -9.65% | $484.21M | vs EVH |
| LINCLincoln Educational Services Corporation | 20.12 | -7.71% | $619.32M | vs EVH |
| EVIEVI Industries Inc. | 19.78 | -5.40% | $256.57M | vs EVH |
| PXEDPhoenix Education Partners Inc. | 19.66 | -4.19% | $721.06M | vs EVH |
| APEIAmerican Public Education Inc. | 39.77 | -2.62% | $723.94M | vs EVH |
| FCFranklin Covey Company | 13.19 | +0.61% | $149.51M | vs EVH |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Evolent Health stock FAQ
What is Evolent Health's stock price today?
EVH last traded at $3.90 as of Nov 20, 4:00 PM EST, up 13.70% on the day. Prices are delayed at least 15 minutes.
Who is Evolent Health's CEO?
Mr. Seth Barrie Blackley is the chief executive officer of Evolent Health Inc Class A, which has about 4,200 employees.
What is the EVH 52-week high?
The 52-week high for EVH is $6.26 and the 52-week low is $2.10. The stock is currently 37.6% below its high.